Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors. - Wikidata - awgldk - TriplyDB

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

http://www.wikidata.org/entity/Q37230530

about

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory Inhibitory potential of subpopulations of CD8+ T cells in HIV-1-infected elite suppressors HIV-1 Vaccine Trials: Evolving Concepts and Designs Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.Immunological and virological characterization of HIV-1 viremia controllers in the North Region of Brazil.Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers.Hepatitis C infection in HIV-1 natural viral suppressors.Hepatitis B vaccine responsiveness and clinical outcomes in HIV controllers.Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.Targeting γδ T cells for immunotherapy of HIV disease Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection.Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection.Host factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study.Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature.A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.Elevated hypermutation levels in HIV-1 natural viral suppressors.Chronic immune activation and decreased CD4 cell counts associated with hepatitis C infection in HIV-1 natural viral suppressors CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants.An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration The implications of viral reservoirs on the elite control of HIV-1 infection.Cell-Mediated Immunity in Elite Controllers Naturally Controlling HIV Viral Load.Finding a cure for human immunodeficiency virus-1 infection.Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.Targeting the Late Stage of HIV-1 Entry for Antibody-Dependent Cellular Cytotoxicity: Structural Basis for Env Epitopes in the C11 Region.Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers.Current Treatment Options for HIV Elite Controllers: a Review HIV control: Is getting there the same as staying there?

P2860

Q27675486-EB13CE69-C0B2-4D74-9582-560B3253B4DF Q28477861-DB4F8DC0-ED8B-4184-976E-DF3A830944CA Q28710569-68CB0044-1DC6-4C05-A3CF-DE04FE4E45A3 Q30425520-13410D3E-70D6-4D28-838F-4BCF6DBDA272 Q33410222-B858C012-8188-4084-B93C-F2A98CF5D3D7 Q33755753-AD92557D-7A4D-46C1-B88A-04100B04FE0C Q33828349-1C4C7B56-8DD1-444C-8C6B-6CA0F835DDC5 Q33952520-F95BA4E1-7447-4CA5-8F75-CA45CE0A0724 Q34075566-DB956ACA-4125-4C80-900F-461F2517CA33 Q34206267-FD88C7EF-6268-43D5-8C19-30F31CFAB434 Q34585223-7FAFCAD0-DEE2-4D34-83B4-A085456EA9D7 Q34611671-57231655-2D28-47F7-8D07-3B0EDBA992F4 Q35001377-91F1BF2F-8640-4256-BEE0-D6D375356810 Q35034034-B2AF8E1D-9B6C-410C-B8B0-0AF50AF3E638 Q35661912-F6230D92-95C5-413B-A1C5-FE547FEB12D4 Q36547178-1EEA94B3-9C1A-4C0A-A01B-9B56ADCDC60C Q36665336-F9A3B79D-2927-4011-8524-FBD674D1A5C8 Q36833017-5A27732C-6B85-4C45-9305-F1A8ACC5C6AD Q36906910-1B2957AC-E01E-46A2-9DDB-50685ECB1DC3 Q37145307-5F2FED6F-0FE7-4C7E-AD2D-529325D8C8E4 Q37169522-0A5FB55B-D0B9-4F82-AF18-406D13F6E344 Q37427587-413E57D3-63F7-482C-B55E-CC0648141823 Q37525462-6F69A945-30B5-4D7D-A166-8346B48AD8A7 Q38032153-3CD38522-2513-4D53-84B4-BD321B4F7256 Q38098176-1FAA5A1D-7788-43CD-B351-29523B643512 Q38256237-36D769DC-9630-49FA-9651-9FD9FB764261 Q39425108-65AB775F-C348-433B-A85F-83072DFAF004 Q40142539-348A7E5C-07DC-4581-AD8E-A743D16826CC Q40695938-7B4A49B4-8F0D-44BE-BB4C-665B9EE2F0E8 Q41444622-F1E54422-01D2-4815-8867-1D7E9551A570 Q41915015-7A9B6766-1A26-4745-A0C5-CE1773982D26 Q41916926-2BD151A8-905A-4D15-A111-C3263C029BB1 Q42737606-4A7D7B90-55A0-4CC6-B7CE-4E44488BF997 Q47604797-CD5C94ED-6055-4FE8-841D-989B8C050896 Q52680990-AB4F52D3-7E0B-4397-95DA-B8975E70555B Q57825309-940A7F71-1132-473E-A23C-EE26F7A6CF05 Q58085173-FF8D008A-99C9-4924-A69F-19EFFB15CD33

P2860

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

http://www.wikidata.org/entity/Q37230530

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@en

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@nl

type

label

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@en

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@nl

prefLabel

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@en

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@nl

P1433

Q37230530-5E727ABA-AA8A-4BF3-B3FD-43FE85A7419C

P1476

Q37230530-201E9932-A6D5-4C98-A39C-25E91A08497F

P2093

Q37230530-09A2C2A7-AD14-4A09-8D8D-5C6C5D1EAA6E

Q37230530-11A0C178-BBE6-4F2A-BBC6-18C9693F9631

Q37230530-52CDBB64-162D-422C-AF58-457E644E290A

Q37230530-7A610BD3-E11E-42C6-8E48-C171CFF65D59

Q37230530-8F5C08F6-8985-47BE-BFFD-3537FED961A5

Q37230530-93E94D5B-317F-4B6F-8C57-F699AC6CE28B

Q37230530-C2671709-DEBC-441B-9161-67D5FDF7D221

P2860

Q37230530-18540719-F80D-4109-8889-98453A97DAC7

Q37230530-1E755680-AE44-4F75-89A3-7730D912EB4A

Q37230530-25BBF376-8DB0-4C8D-B05B-18B663D4617B

Q37230530-741EC6AF-40CD-4C26-922B-2B52B51A8083

Q37230530-75111DFE-0175-4820-9DD9-889BD3ECCE8E

Q37230530-7D27F3C6-91EC-4130-A6CA-B3B20EEC3CA3

Q37230530-8FCED02E-2F1D-4017-8640-F42498550925

Q37230530-9428611B-A9FF-4112-AF6D-069B83FCADD6

Q37230530-A16D8BAE-0CE2-42D5-81BB-B6E34CC3DBFF

Q37230530-B92A4C88-B2EE-4664-893F-AFB936511B5F

P304

Q37230530-8DF90650-3A78-48A7-B9D5-C9991A6C58F6

P31

Q37230530-508A4E7B-37EF-433F-8BAA-9D2F680A556A

P356

Q37230530-0BECC293-D7BC-4131-A757-A720B944E49A

P407

Q37230530-6B17C28C-C3DC-4B6F-9737-49902C43B40E

P433

Q37230530-64900489-85B6-4908-9506-2712ED339E96

P478

Q37230530-7538CADB-B38C-41B0-8D82-7D0DB8B2940E

P577

Q37230530-61C6A869-AB5E-4093-9FE5-4B03DCEDB56C

P698

Q37230530-00856052-6F93-4D2F-81B6-853C14917407

P921

Q37230530-61EEBC4C-A382-4B26-A43F-08965DEB531D

P932

Q37230530-69B3E35A-262E-41C1-B7CA-6F7ABAB12350

P356

QAI.0B013E3181945F1E

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

@en

P2093

Dean L Mann

http://www.w3.org/2001/XMLSchema#string

Elham Dadzan

http://www.w3.org/2001/XMLSchema#string

Manhattan Charurat

http://www.w3.org/2001/XMLSchema#string

Mohammad M Sajadi

http://www.w3.org/2001/XMLSchema#string

Neil T Constantine

http://www.w3.org/2001/XMLSchema#string

Peter Kadlecik

http://www.w3.org/2001/XMLSchema#string

Robert R Redfield

http://www.w3.org/2001/XMLSchema#string

P2860

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy.

Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load

HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry.

P304

403-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181945F1E

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19214118

http://www.w3.org/2001/XMLSchema#string

P921

P932

2697612

http://www.w3.org/2001/XMLSchema#string